Deal of the Day — limited-time pharmacy picks!
Bdenza 160mg Tablet

Bdenza 160mg Tablet

Prescription requiredRx Required

Salt Composition: Enzalutamide

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

7 Tablet(s) In A Strip

About The Product

Prostate Cancer

Bdenza 160 mg is a prescription-based medication. The oral solution's active component, enzalutamide, is an androgen receptor inhibitor that is classified as an antineoplastic medication. Only men are advised to use it; women, and especially those who are becoming pregnant or nursing, should not use this solution without gloves.

Benefits

Advanced prostate cancer

How To Use

  • It is advised to use Bdenza 160 mg tablet as directed by the doctor.
  • The common side effects of this tablet are: Trouble breathing (pneumonia), feeling tired Back pain diarrhoea cold headache insomnia high blood pressure swelling in arms, legs, feet, or hands

How It Works

Bdenza 160 mg tablet should always be taken after the doctor's instructions; it is not a self-medication drug. It can be taken without or with food, as suggested by the doctor.

Bdenza 160 mg tablet should not be chewed, opened, or crushed; it must be swallowed to increase the effectiveness of the drug. It is an oral medication that is taken once a day, at the same time each day, before food.

One should wait for at least 3 hours before taking the Bdenza 160 mg tablet

Safety Advice

Alcohol
Drinking too much alcohol could damage a person's immunity and liver function. Alcohol consumption can cause dizziness, confusion, tiredness, and cognitive impairment, so it is advised not to consume alcohol while taking Bdenza 160 mg tablet.
Pregnancy
It is not advised to take the Bdenza 160 mg tablet when pregnant because it affects the fetus. This solution is not for use in women.
Breast Feeding
Because there is a possibility that the Bdenza 160 mg tablet could be transferred to the developing infant through the mother's breast milk, it is not advised to consume it while nursing. It is widely regarded as dangerous, and there is not enough evidence in the clinical data on its adverse impacts on infants.
Driving
Taking a Bdenza 160 mg tablet while operating machinery may cause confusion or affect one's capacity to drive. The capsule may cause neurological side effects, such as fever or feeling dizzy. Until you feel better, don't drive
Kidney
People with kidney issues can use the Bdenza 32mg Solution after consulting with the doctor. It may harm the kidneys if taken on self-medication.
Liver
People with severe liver illness should not use the Bdenza 160 mg tablet. Whereas people with mild liver disease can use this solution, but it must be regularly monitored. Use caution and alter the dosage of the Bdenza 160 mg tablet as advised by your doctor.

FAQs

It is advised not to take alcohol while taking the Bdenza 160mg tablet, because consuming alcohol can cause serious side effects and can damage your liver badly.

Consult your doctor if you have concerns or queries.

Reference

Akaza H, Uemura H, Tsukamoto T, Ozono S, Ogawa O, Sakai H, Oya M, Namiki M, Fukasawa S, Yamaguchi A, Uemura H, Ohashi Y, Maeda H, Saito A, Takeda K, Naito S. (2025).

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer. Int J Clin Oncol.

21(4):773-782. Hussain, M., Fizazi, K., Saad, F., Rathenborg, P., Shore, N., Ferreira, U., & Sternberg, C.

N. (2025).

Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. New England Journal of Medicine, 378(26), 2465-2474.

Penson, D. F., Armstrong, A.

J., Concepcion, R., Agarwal, N., Olsson, C., Karsh, L., & Higano, C. S.

(2025). Enzalutamide versus bicalutamide in castration-resistant prostate cancer: the STRIVE trial.

Journal of Clinical Oncology, 34(18), 2098-2106. Perimbeti, S., Jamroze, A., Gopalakrishnan, D., Jain, R., Jiang, C., Holleran, J.

L., & Chatta, G. (2025).

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology, 95(1), 115.

Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P.

A., Arora, V., & Sawyers, C. L.

(2010). Development of a second-generation antiandrogen for treatment of advanced prostate cancer.

Science, 324(5928), 787-790.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026